CureVac NV (CVAC)
3.10
-0.06
(-1.90%)
USD |
NASDAQ |
Dec 16, 16:00
3.09
-0.01
(-0.32%)
After-Hours: 05:49
CureVac Shareholders Equity (Quarterly): 809.41M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioNTech SE | 21.35B |
| Bayer AG | 34.13B |
| Affimed NV | 19.21M |
| InflaRx NV | 72.91M |
| Immatics NV | 427.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 954.04M |
| Total Liabilities (Quarterly) | 144.63M |
| Current Ratio | 6.197 |